Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis. (Q53520815)

15 May 2018

title

Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis. (English)

1 reference

15 May 2018

0 references

1 reference

Hyo-Sun Choi

1

1 reference

15 May 2018

Jung-Woo Kang

series ordinal

2

1 reference

15 May 2018

Sun-Mee Lee

series ordinal

3

1 reference

15 May 2018

publication date

12 April 2015

1 reference

15 May 2018

published in

Translational Research

1 reference

15 May 2018

volume

166

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

292-303

1 reference

15 May 2018

Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Necroptosis as an alternative form of programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Necrostatin: a potentially novel cardioprotective agent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

RIPK3-mediated necroptosis regulates cardiac allograft rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin: a multitasking molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Analysis of the daily changes of melatonin receptors in the rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia/reperfusion injury in rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Hepatoprotective effects of melatonin against pronecrotic cellular events in streptozotocin-induced diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin inhibits mTOR-dependent autophagy during liver ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Mechanisms and biomarkers of apoptosis in liver disease and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Programmed necrosis: backup to and competitor with apoptosis in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Molecular mechanisms of necroptosis: an ordered cellular explosion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin prevents H2O2-induced activation of rat hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin prevents disruption of hepatic reactive oxygen species metabolism in rats treated with carbon tetrachloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Inhibition of carbon tetrachloride-mediated apoptosis and oxidative stress by melatonin in experimental liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Postoperative mortality and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

HMGB1 cytoplasmic translocation in patients with acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Release of interleukin-1α or interleukin-1β depends on mechanism of cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Interleukin-1 participates in the progression from liver injury to fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

TLR4 enhances TGF-beta signaling and hepatic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.04.002

10.1016/J.TRSL.2015.04.002

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018